Skip to content

Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System

Phase 1 Study of Liver Machine Preservation With Vasosol Solution

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00879268
Enrollment
20
Registered
2009-04-09
Start date
2004-07-31
Completion date
2009-02-28
Last updated
2009-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation, Organ Preservation

Keywords

Liver Transplantation, Organ Preservation, Liver Preservation, Machine Perfusion, Vasosol, Machine Preservation

Brief summary

This is a pilot trial of centrifugal machine preservation of donor livers for transplantation using a novel preservation solution.

Interventions

DEVICEVasosol Organ Perfusion Solution and Medtronic Portable Bypass System

Utilization of Vasosol with Medtronic System for Machine Preservation of the Liver for Liver Transplantation

Sponsors

Health Resources and Services Administration (HRSA)
CollaboratorFED
Polyak, Maximilian
Lead SponsorINDIV

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Primary/ Solitary Liver Transplant * Lab MELD\<35 * Donor age \<65

Exclusion criteria

* Donor Liver \> 30% Macrosteatosis * DCD donor liver * Multi-organ Recipient * Recipient in ICU * Retransplant

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026